Clinical Trials Directory

Trials / Unknown

UnknownNCT05871515

3D Ultrasound of Abdominal Aortic Aneurysm Characteristics

3D Ultrasound of Abdominal Aortic Aneurysm Characteristics for Predicting Aneurysm Shrinkage After Endovascular Repair

Status
Unknown
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
Rijnstate Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

AAA characteristics are traditionally measured with computed tomography angiography (CTA), however, three-dimensional ultrasound (3D US) is emerging as a novel imaging method for AAAs. With the use of a US contrast agent, the AAA thrombus can also be distinguished from the lumen on the 3D scans. This enables 3D visualization of the AAA and its thrombus without the need for harmful radiation and nephrotoxic contrast agents, as opposed to CTA. In in vitro measurements, 3D US has already been shown to have clinically acceptable error rate with AAA diameter and volume measurement. However, it is unclear whether this is also applicable to in vivo measurements. Therefore, the aim of this prospective study is to compare preoperative 3D US AAA characteristics as measured by 3D US with contrast enhancement (3D CEUS), 3D US without contrast enhancement (3D non-CEUS) and CTA.

Conditions

Interventions

TypeNameDescription
DEVICE3D ultrasoundA 3D ultrasound is performed preoperatively to measure various aneurysm characteristics

Timeline

Start date
2022-12-27
Primary completion
2023-12-13
Completion
2025-01-01
First posted
2023-05-23
Last updated
2024-02-01

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05871515. Inclusion in this directory is not an endorsement.